#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive Activated PI3 kinase delta syndrome Pyoderma gangrenosum Cerebral amyloid angiopathy Giant cell tumour of tendon sheath Prolymphocytic leukaemia Epilepsy with myoclonic-atonic seizures Type IIa hyperlipidaemia Immune thrombocytopenia Optic glioma Glomerulonephritis chronic Nasopharyngeal cancer Gastrointestinal disorder Antiphospholipid antibodies Pneumonia More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Life with Disease Basal cell naevus syndrome – Life with Disease X-linked lymphoproliferative syndrome – Life with Disease Hereditary ataxia Langerhans cell sarcoma – Diagnostics Chondrosarcoma – Trials in Disease Malignant fibrous histiocytoma – Basic Information Synovial sarcoma Marginal zone lymphoma – Diagnostics Amyotrophic lateral sclerosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubiquinol Tiotropium Bromide Monohydrate Insulin Glargine Thiamine Tamuzimod Acetate CYCLIZINE HYDROCHLORIDE Emiplacel Nazartinib Taxanes FERUMOXTRAN-10 Utreglutide Tafamidis ZILEBESIRAN VAMIFEPORT TRIHYDROCHLORIDE Teicoplanin Lactulose Peppermint Oil Water For Injections Cinnarizine BI 456906 More therapies…

    Learn about Your Condition

    Fabry's disease Food allergy Apheresis Adrenal insufficiency Ovarian cancer stage IV Crigler-Najjar syndrome Arteriovenous malformation Uveitis Noninfective chorioretinitis Malignant mast cell neoplasm Supraventricular tachycardia Peripheral artery restenosis Macular degeneration Deep vein thrombosis Measles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatitis B

  • Study on the Safety and Immune-Enhancing Effects of Pomalidomide in Patients with Chronic Hepatitis B Infection

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hepatitis B
    Investigated Drugs:
    • Pomalidomide
    Denmark

  • Study on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    • Elebsiran
    • Tobevibart
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Study on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    • Elebsiran
    • Tobevibart
    Austria France Germany Italy Romania Spain

  • Study on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    France Germany Romania

  • Study on Bepirovirsen for Patients with HIV and Chronic Hepatitis B on Antiretroviral Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Hepatitis B
    France Italy Spain

  • Study on the Effects of VIR-2218 and VIR-3434 for Patients with Chronic Hepatitis D Infection

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    Bulgaria France Germany Italy The Netherlands Romania
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!